Metformin and sitagliptin in patients with impaired glucose tolerance and a recent TIA or minor ischemic stroke: A multicenter, randomized, open-label phase II trial.

Trial Profile

Metformin and sitagliptin in patients with impaired glucose tolerance and a recent TIA or minor ischemic stroke: A multicenter, randomized, open-label phase II trial.

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Jan 2015

At a glance

  • Drugs Metformin (Primary) ; Sitagliptin (Primary)
  • Indications Glucose intolerance
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms MAAS
  • Most Recent Events

    • 14 Jul 2012 Actual initiation date (4 Jul 2012) added as reported by European Clinical Trials Database record.
    • 14 Jul 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2011-005980-26).
    • 04 Jul 2012 Status changed from planning to recruiting as reported by European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top